JP7748105B2 - ウイルス感染の判定方法 - Google Patents

ウイルス感染の判定方法

Info

Publication number
JP7748105B2
JP7748105B2 JP2022544621A JP2022544621A JP7748105B2 JP 7748105 B2 JP7748105 B2 JP 7748105B2 JP 2022544621 A JP2022544621 A JP 2022544621A JP 2022544621 A JP2022544621 A JP 2022544621A JP 7748105 B2 JP7748105 B2 JP 7748105B2
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
protein
mda5
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022544621A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022045126A1 (https=
JPWO2022045126A5 (https=
Inventor
友昭 星野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kurume University
Original Assignee
Kurume University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurume University filed Critical Kurume University
Publication of JPWO2022045126A1 publication Critical patent/JPWO2022045126A1/ja
Publication of JPWO2022045126A5 publication Critical patent/JPWO2022045126A5/ja
Application granted granted Critical
Publication of JP7748105B2 publication Critical patent/JP7748105B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
    • C12Y306/04—Hydrolases acting on acid anhydrides (3.6) acting on acid anhydrides; involved in cellular and subcellular movement (3.6.4)
    • C12Y306/04013—RNA helicase (3.6.4.13)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
JP2022544621A 2020-08-25 2021-08-24 ウイルス感染の判定方法 Active JP7748105B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020141874 2020-08-25
JP2020141874 2020-08-25
PCT/JP2021/030976 WO2022045126A1 (ja) 2020-08-25 2021-08-24 ウイルス感染の判定方法

Publications (3)

Publication Number Publication Date
JPWO2022045126A1 JPWO2022045126A1 (https=) 2022-03-03
JPWO2022045126A5 JPWO2022045126A5 (https=) 2024-03-18
JP7748105B2 true JP7748105B2 (ja) 2025-10-02

Family

ID=80353713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544621A Active JP7748105B2 (ja) 2020-08-25 2021-08-24 ウイルス感染の判定方法

Country Status (4)

Country Link
US (1) US20230314433A1 (https=)
EP (1) EP4206221A4 (https=)
JP (1) JP7748105B2 (https=)
WO (1) WO2022045126A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL308258A (en) 2021-05-05 2024-01-01 Immatics Biotechnologies Gmbh Bma031 antigen binding polypeptides
CN121537524B (zh) * 2026-01-20 2026-04-28 江西省人民医院 一种mda5人源化单克隆抗体及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010024089A1 (ja) 2008-09-01 2010-03-04 学校法人慶應義塾 皮膚筋炎の診断方法および診断キット
JP2019520042A (ja) 2016-06-07 2019-07-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 細菌感染及びウイルス感染を診断するための方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229822B1 (en) * 2000-02-29 2007-06-12 Univ Columbia Melanoma differentation associated gene-5 and vectors and cells containing same
CN103336133A (zh) * 2013-07-09 2013-10-02 上海交通大学医学院附属瑞金医院 一种用于检测抗mda5抗体的试剂盒及其检测方法
CN104450626B (zh) * 2014-11-26 2017-02-22 东北农业大学 抗chMDA5蛋白单克隆抗体及其制备方法和应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010024089A1 (ja) 2008-09-01 2010-03-04 学校法人慶應義塾 皮膚筋炎の診断方法および診断キット
JP2019520042A (ja) 2016-06-07 2019-07-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 細菌感染及びウイルス感染を診断するための方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
高岡晃教、橋爪芽衣，ウイルス感染におけるインターフェロン応答の分子機構，医学のあゆみ，日本，2018年06月30日，Vol.265,No.13，PP.1159-1169

Also Published As

Publication number Publication date
EP4206221A1 (en) 2023-07-05
US20230314433A1 (en) 2023-10-05
JPWO2022045126A1 (https=) 2022-03-03
EP4206221A4 (en) 2024-10-16
WO2022045126A1 (ja) 2022-03-03

Similar Documents

Publication Publication Date Title
CN112250763B (zh) 靶向SARS-CoV-2冠状病毒的抗体及其诊断和检测用途
CN111690058B (zh) 针对冠状病毒的具有中和活性的抗体及其用途
CN116063516B (zh) 抗Claudin18.2抗体及其应用
CN110240653B (zh) 抗gp73单克隆抗体和获得抗gp73单克隆抗体的方法
JP2020182467A (ja) Ｂｍｐ６を標的とする抗体のための組成物および方法
CN104144947B (zh) 用于诊断和治疗铁相关病症的组合物和方法
KR20110047193A (ko) 중화 항-인플루엔자 ａ 바이러스 항체 및 이의 용도
AU2017237543A1 (en) Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus, and use for same
CA2853637A1 (en) Anti-canine cd20 monoclonal antibodies and methods of use
AU2014293154A1 (en) Anti-galectin-1 monoclonal antibodies and fragments thereof
TWI756621B (zh) 新型雙特異性抗體分子以及同時結合pd-l1和lag-3的雙特異性抗體
CN107001480B (zh) 用于人c-maf的结合成员
CN104136462A (zh) 用于诊断和治疗铁相关病症的组合物和方法
JP2016529909A (ja) Ｎａｖ１．７抗体及び前記抗体を使用する方法
JP7748105B2 (ja) ウイルス感染の判定方法
CN121358774A (zh) 与nkg2a结合的抗体或抗原结合片段及其用途
CN121219584A (zh) 针对nr1的自身抗体的检测
WO2023109419A1 (en) A neutralizing antibody that can bind sars-cov-2 virus and its application
WO2024146419A1 (zh) 一种Claudin-18.2特异性抗体及其应用
CN120225680A (zh) 针对外被体蛋白复合物亚基β2的抗体
US20230391854A1 (en) Monoclonal antibody for coronavirus spike protein, and use thereof
US20230408517A1 (en) Anti-severe acute respiratory syndrome coronavirus antibodies
KR20230042301A (ko) 샘플에서 sars-cov-2 단백질을 검출하기 위한 개선된 방법 및 키트
TW201915016A (zh) 單株抗體或其抗原結合片段及其用途
TW202313681A (zh) Ｍａｇｅｂ２結合構建體

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240307

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240307

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241112

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250617

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250804

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250902

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250911

R150 Certificate of patent or registration of utility model

Ref document number: 7748105

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150